Changes in PACAP immunoreactivity in human milk and presence of PAC1 receptor in mammary gland during lactation

Journal of Molecular Neuroscience

Volumn 48, Issue 3, 2012, Pages 631-637

  Csanaky, Katalin ^a   Banki, Eszter ^a   Szabadfi, Krisztina ^a   Reglodi, Dora ^a   Tarcai, Ibolya ^b   Czegledi, Levente ^c   Helyes, Zsuzsanna ^a   Ertl, Tibor ^a   Gyarmati, Judit ^a   Szanto, Zalan ^a   Zapf, Istvan ^a   Sipos, Erika ^a   Shioda, Seiji ^d   Tamas, Andrea ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Unified Health Institutions   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d SHOWA UNIVERSITY   (Japan)

Author keywords

Human milk; Mammary gland; PAC1; PACAP38

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 2; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

ARTICLE; BREAST MILK; COLOSTRUM; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOREACTIVITY; LACTATION; MAMMARY GLAND; NONHUMAN; NORMAL HUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SHEEP;

ANIMALS; BREAST; COLOSTRUM; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LACTATION; MAMMARY GLANDS, ANIMAL; MILK, HUMAN; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; SHEEP, DOMESTIC; SPECIES SPECIFICITY;

OVIS ARIES;

EID: 84868200506     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-012-9779-4     Document Type: Article

References (51)

1. Anderson ST, Sawangjaroen K, Curlewis JD (1996) Pituitary adenylate cyclase-activating polypeptide acts within the medial basal hypothalamus to inhibit prolactin and luteinizing hormone secretion. Endocrinology 137:3424-3429 (Pubitemid 26250194)
2. Arbogast LA, Voogt JL (1994) Pituitary adenylate cyclase-activating polypeptide (PACAP) increases prolactin release and tuberoinfundibular dopaminergic neuronal activity. Brain Res 655:17-24 (Pubitemid 24262987)
3. Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy DH, Kitada C (1991) Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology 129:2787-2789
4. Aydin S, Aydin S, Ozkan Y, Kumru S (2006) Ghrelin is present in human colostrums, transitional and mature milk. Peptides 27:878- 882
5. Baintner K (2007) Transmission of antibodies from mother to young: evolutionary strategies in a proteolytic environment. Vet Immunol Immunopathol 117:153-161 (Pubitemid 46702322)
6. Borzsei R, Mark L, Tamas A et al (2009) Presence of pituitary adenylate cyclase activating polypeptide-38 in human plasma and milk. Eur J Endocrinol 160:561-565
7. Bourgault S, Chatenet D, Wurtz O et al (2011) Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug. Curr Pharm Des 17:1002-1024
8. Brubel R, Reglodi D, Jambor E et al (2011) Investigation of pituitary adenylate cyclase activating polypeptide in human gynecological and other biological fluids by using MALDI TOF mass spectrometry. J Mass Spectrom 46:189-194
9. Catinella S, Traldi P, Pinelli C, Dallaturca E, Marsilio R (1996) Matrixassisted laser desorption/ionization mass spectrometry in milk science. Rapid Commun Mass Spectrom 10:1629-1637 (Pubitemid 27040295)
10. Chiodera P, Volpi R, Capretti L, Coiro V (1995) Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on arginine vasopressin and oxytocin secretion in man. Neuroreport 6:1490-1492
11. Chiodera P, Volpi R, Capretti L, Caffarri G,Magotti MG, Coiro V (1996) Effects of intravenously infused pituitary adenylate cyclaseactivating polypeptide on adenohypophyseal hormone secretion in normal men. Neuroendocrinology 64:242-246 (Pubitemid 26280817)
12. Chowanadisai W, Lonnerdal B (2002) Alpha(1)-antitrypsin and antichymotrypsin in human milk: origin, concentrations, and stability. Am J Clin Nutr 76:828-833
13. Cohick WS (1998) Role of the insulin-like growth factors and their binding proteins in lactation. J Dairy Sci 81:1769-1777 (Pubitemid 128449327)
14. Czegledi L, Tamas A, Borzsei R et al (2011) Presence of pituitary adenylate cyclase-activating polypeptide (PACAP) in the plasma and milk of ruminant animals. Gen Comp Endocrinol 172:115-119
15. Eilers E, Ziska T, Harder T, Plagemann A, Obladen M, Loui A (2011) Leptin determination in colostrum and early human milk from mothers of preterm and term infants. Early Hum Dev 87:415-419
16. Falluel-Morel A, Aubert N, Vaudry D et al (2008) Interactions of PACAP and ceramides in the control of granule cell apoptosis during cerebellar development. J Mol Neurosci 36:8-15
17. Ganea D, Delgado M (2003) The neuropeptides VIP/PACAP and T cells: inhibitors or activators? Curr Pharm Des 9:997-1004 (Pubitemid 36443201)
18. Garcia-Fernandez MO, Bodega G, Ruiz-Villaespesa A, Cortes J, Prieto JC, Carmena MJ (2004) PACAP expression and distribution in human breast cancer and healthy tissue. Cancer Lett 205:189-195 (Pubitemid 38230126)
19. Garcia-Fernandez MO, Collado B, Bodega G et al (2005) Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue. Gynecol Endocrinol 20:327-333 (Pubitemid 40978804)
20. Grosvernor CE, Picciano MF, Baumrucker CR (1992) Hormones and growth factors in milk. Endocr Rev 14:710-728 (Pubitemid 24016658)
21. Hartmann PE, Kulski JK (1978) Changes in the composition of the mammary secretion of women after abrupt termination of breast feeding. J Physiol 275:1-11 (Pubitemid 8279712)
22. Hashimoto H, Shintani N, Tanida M, Hayata A, Hashimoto R, Baba A (2011) PACAP is implicated in the stress axes. Curr Pharm Des 17:985-989
23. Helyes Zs, Pozsgai G, Borzsei R et al (2007) Inhibitory effect of PACAP38 on acute neurogenic and non-neurogenic inflammation in the rat. Peptides 28:1847-1855 (Pubitemid 47361436)
24. Huang SK, Pan JT (1996) Stimulatory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide on tuberoinfundibular dopaminergic neuron activity in estrogen-treated ovariectomized rats and their correlation with prolactin secretion. Neuroendocrinology 64:208-214
25. Jarmołowska B, Sidor K, Iwan M et al (2007) Changes of betacasomorphin qcontent in human milk during lactation. Peptides 28:1982-1986 (Pubitemid 47422384)
26. Kelly GS (2003) Bovine colostrums: a review of clinical uses. Altern Med Rev 8:378-994
27. Knobil E, Neill JD (1998) Encyclopedia of reproduction. Academic, London
28. Koppan M, Varnagy A, Reglodi D et al (2012) Correlation between oocyte number and follicular fluid concentration of pituitary adenylate cyclase activating polypeptide (PACAP) in women after superovulation treatment. J Mol Neurosci. doi:10.1007/s12031- 012-9743-3
29. Leyton J, Gozes Y, Pisegna J et al (1999) PACAP(6-38) is a PACAP receptor antagonist for breast cancer cells. Breast Cancer Res Treat 56:177-186 (Pubitemid 29494835)
30. Lonnerdal B (2003) Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr 77:1537S-1543S
31. Lu M, Yao F, Guo A (1995) A study on two gut hormones in breast milk. Zhonghua Fu Chan Ke Za Zhi 30:554-556
32. McFarland-Mancini M, Hugo E, Loftus J, Ben-Jonathan N (2006) Induction of prolactin expression and release in human preadipocytes by cAMP activating ligands. Biochem Biophys Res Commun 344:9-16
33. Moody TW, Gozes I (2007) Vasoactive intestinal peptide receptors: a molecular target in breast and lung cancer. Curr Pharm Des 13:1099-1104 (Pubitemid 46739339)
34. Moody TW, Leyton J, Gozes I, Lang L, Eckelman WC (1998) VIP and breast cancer. Ann N Y Acad Sci 865:290-296 (Pubitemid 29047838)
35. Moody TW, Leyton J, Chan D et al (2001) VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells. Breast Cancer Res Treat 68:55-64 (Pubitemid 32928271)
36. Nemeth J, Reglodi D, Pozsgai G et al (2006) Effect of PACAP-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice. Neuroscience 143:223-230 (Pubitemid 44755233)
37. Reglodi D, Gyarmati J, Ertl T et al (2010) Alterations of pituitary adenylate cyclase-activating polypeptide-like immunoreactivity in the human plasma during pregnancy and after birth. J Endocrinol Invest 33:443-445
38. Reglodi D, Kiss P, Lubics A, Tamas A (2011) Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr Pharm Des 17:962-972
39. Reubi JC, Laderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA (2000) Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res 60:3105-3112 (Pubitemid 30395841)
40. Sakurai Y, Shintani N, Hayata A, Hashimoto H, Baba A (2011) Trophic effects of PACAP on pancreatic islets: a mini-review. J Mol Neurosci 43:3-7
41. Sawangjaroen K, Curlewis JD (1994) Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on prolactin, luteinizing hormone and growth hormone secretion in the ewe. J Neuroendocrinol 6:549-555 (Pubitemid 24315331)
42. Seaborn T, Masmoudi-Kouli O, Fournier A, Vaudry H, Vaudry D (2011) Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis. Curr Pharm Des 17:204- 214
43. Skakkebaek M, Hannibal J, Fahrenkrug J (1999) Pituitary adenylate cyclase activating polypeptide (PACAP) in the rat mammary gland. Cell Tissue Res 298:153-159 (Pubitemid 29460514)
44. Somogyvari-Vigh A, Reglodi D (2004) Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr Pharm Des 10:2861-2889 (Pubitemid 39172068)
45. Svennersten-Sjaunja K, Olsson K (2005) Endocrinology of milk production. Domest Anim Endocrinol 29:241-258 (Pubitemid 40920118)
46. Tohei A, MatsuzakiM, Kogo H (2001) Antagonist of pituitary adenylate cyclase activating polypeptide suppresses prolactin secretion without changing the activity of dopamine neurons in lactating rats. Neuroendocrinology 73:68-74 (Pubitemid 32171112)
47. Vaudry D, Falluel-Morel A, Bourgault S et al (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283-357
48. Weaver LT (1992) Breast and gut: the relationship between lactating mammary function and neonatal gastrointestinal function. Proc Nutr Soc 51:155-163
49. Werner H, Koch Y, Fridkin M, Fahrenkrug J, Gozes I (1985) High levels of vasoactive intestinal peptide in human milk. Biochem Biophys Res Commun 133:228-232 (Pubitemid 16155350)
50. Yoshioka Y, Kudo S, Nishimura H et al (2005) Oral administration of bovine colostrum stimulates intestinal intraepithelial lymphocytes to polarize Th1-type in mice. Int Immunopharmacol 5:581-590 (Pubitemid 40430764)
51. Zia H, Hida T, Jakowlew S et al (1996) Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist. Cancer Res 56:3486-3489 (Pubitemid 26251641)